Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: Phase III randomised placebo controlled trial (MIR)
- Submitting institution
-
University of Exeter
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 340
- Type
- D - Journal article
- DOI
-
10.1136/bmj.k4218
- Title of journal
- BMJ (Online)
- Article number
- ARTN k4218
- First page
- -
- Volume
- 363
- Issue
- -
- ISSN
- 0959-8146
- Open access status
- Compliant
- Month of publication
- October
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
https://www.bmj.com/highwire/filestream/986775/field_highwire_adjunct_files/0/kesd045206.ww1.pdf
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
18
- Research group(s)
-
B - Primary Care Research
- Citation count
- 12
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author, CMD, made a substantial contribution to the organisation of the conduct of the study, to carrying out the study and to the interpretation of study data. CMD helped critique the output for important intellectual content. CMD was co-applicant.
- Non-English
- No
- English abstract
- -